Search Results 41-50 of 19117 for prostate cancer
... in response to abiraterone acetate/prednisone, a standard treatment option for men with progressive, incurable and castration-resistant prostate cancer.
"The reality is that prostate cancer is the most commonly diagnosed solid malignancy in men," says Dr. Eugene Kwon, a Mayo Clinic urologist. Dr. Kwon says, ...
Prostate cancer that is more advanced may cause trouble urinating, blood in the semen, erectile dysfunction and more. Make an appointment with your doctor if ...
There's no proven prostate cancer prevention strategy. But you may reduce your risk of prostate cancer by making healthy choices, such as exercising and eating ...
This proposal's long-range objective is to improve outcomes for patients with hepatocellular carcinoma (HCC). HCC is a major global burden of morbidity and ...
High-intensity focused ultrasound (HIFU) allows specialists to treat only the area of the most aggressive tumor while leaving the rest of the prostate and ...
Metastatic castration-resistant prostate cancer presents treatment challenges, including the side effects of chemotherapy. Mayo Clinic researchers find that ...
Prostate cancer is the second most common cancer in men worldwide. It's important that men are screened for the disease to catch it early, and a study in ...
“Prostate cancer is different in every patient." says Dr. Kohli. "In this groundbreaking study, we explored thousands of genetic characteristics in each tumor, ...
Prostate Cancer. Polygenic risk. People with high polygenic risk scores are 2 to 4 times more likely to get prostate cancer than are people who aren't in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.